Plasma potassium changes in anuric hyperglycemia treated with insulin

Area of Science:

• Endocrinology
• Nephrology
• Metabolic Disorders

Background:

• Hyperglycemia is common in patients with kidney failure.
• Insulin is often used to manage hyperglycemia, but its effect on potassium levels in anuric patients is not fully understood.
• Potassium homeostasis is critical, especially in patients with impaired kidney function.

Purpose of the Study:

• To investigate the sequential changes in plasma potassium concentration in anuric, hyperglycemic patients treated solely with insulin.
• To determine the relationship between initial plasma potassium levels and the subsequent changes during insulin therapy.
• To assess the need for potassium supplementation in such patients.

Main Methods:

• Sequential monitoring of plasma potassium concentration in five anuric, hyperglycemic patients.
• Patients received only insulin treatment.
• Acid-base balance, external potassium and fluid balance, and body weights were monitored and remained stable.

Main Results:

• A significant decrease in plasma potassium was observed in patients with initial hyperkalemia (delta K = -1.8 +/- 0.1 mmol/l, p < 0.005).
• A normokalemic patient showed a decrease in plasma potassium (delta K = -1.3 mmol/l).
• A hypokalemic patient experienced a slight increase in plasma potassium (delta K = +0.1 mmol/l).
• A strong negative correlation (r = -0.88, p = 0.05) was found between initial potassium concentration and the change in potassium concentration.

Conclusions:

• In anuric hyperglycemia treated solely with parenteral insulin, plasma potassium changes are dependent on baseline potassium levels.
• Hyperkalemic patients demonstrate a shift towards normokalemia.
• Hypokalemic patients may not require potassium replacement, as their levels might not decrease significantly.